Variant report
Variant | nsv527807 |
---|---|
Chromosome Location | chr12:29597846-29598480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OVCH1 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11050234 | chr12:29597846-29597847 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs570730221 | chr12:29597895-29597896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535171538 | chr12:29597929-29597930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191600372 | chr12:29597938-29597939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568136673 | chr12:29597997-29597998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182660269 | chr12:29598028-29598029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377667755 | chr12:29598056-29598057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529345319 | chr12:29598090-29598091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575643057 | chr12:29598097-29598098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539759857 | chr12:29598114-29598115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141085430 | chr12:29598134-29598135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544648049 | chr12:29598145-29598146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10160999 | chr12:29598156-29598157 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs540383324 | chr12:29598166-29598167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559633169 | chr12:29598193-29598194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369948564 | chr12:29598196-29598197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574874878 | chr12:29598246-29598247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373361800 | chr12:29598252-29598253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376321397 | chr12:29598253-29598254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74678553 | chr12:29598258-29598259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530782671 | chr12:29598259-29598260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372898794 | chr12:29598260-29598261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552476710 | chr12:29598261-29598262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564396170 | chr12:29598268-29598269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377100698 | chr12:29598283-29598284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528717043 | chr12:29598284-29598285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7967676 | chr12:29598292-29598293 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs374193920 | chr12:29598331-29598332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73278719 | chr12:29598341-29598342 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs574214099 | chr12:29598360-29598361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7133304 | chr12:29598373-29598374 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs376111615 | chr12:29598378-29598379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557752194 | chr12:29598407-29598408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187080394 | chr12:29598437-29598438 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs558094506 | chr12:29598478-29598479 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs11050235 | chr12:29598480-29598481 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:29581600-29604200 | Weak transcription | HSMMtube | muscle |
2 | chr12:29581800-29613600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
3 | chr12:29584200-29641800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr12:29588000-29607600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr12:29588000-29639800 | Weak transcription | Aorta | Aorta |
6 | chr12:29589600-29598200 | Weak transcription | HSMM | muscle |
7 | chr12:29594200-29600600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr12:29594200-29614000 | Weak transcription | Left Ventricle | heart |
9 | chr12:29598200-29598400 | Enhancers | HSMM | muscle |
10 | chr12:29598400-29657400 | Weak transcription | HSMM | muscle |